ALBIREO PHARMA, INC.·4

Apr 25, 4:41 PM ET

Mattsson Jan 4

4 · ALBIREO PHARMA, INC. · Filed Apr 25, 2022

Insider Transaction Report

Form 4
Period: 2022-04-22
Mattsson Jan
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2022-04-22$32.92/sh200$6,58558,166 total
Footnotes (2)
  • [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F2]Represents 32,784 shares of common stock and 25,382 restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION